Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 26, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

December 30, 2022

Conditions
PharmacokineticsSafety
Interventions
BEHAVIORAL

Test Preparation-Reference preparation

Under fasting conditions, subjects randomly divided into TR group were given one tablet of test preparation first, and then one tablet of reference preparation after cleaning period.

BEHAVIORAL

Reference preparation-Test Preparation

Under fasting conditions, subjects randomly divided into RT group were given one tablet of reference preparation first, and then one tablet of test preparation after cleaning period.

All Listed Sponsors
collaborator

Changzhou Pharmaceutical Factory Co., Ltd

UNKNOWN

lead

The Affiliated Hospital of Qingdao University

OTHER